TUDOR INVESTMENT CORP ET AL - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 202 filers reported holding MYRIAD GENETICS INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$166,110
-84.0%
10,356
-76.8%
0.00%
-83.3%
Q2 2023$1,035,659
+102746.0%
44,679
+3.1%
0.01%
-25.0%
Q1 2023$1,007
+83.1%
43,338
+14.3%
0.02%
+45.5%
Q4 2022$550
-99.9%
37,925
-5.8%
0.01%
-35.3%
Q3 2022$768,000
+13.9%
40,241
+8.4%
0.02%
-5.6%
Q2 2022$674,000
-36.0%
37,120
-11.1%
0.02%
-28.0%
Q1 2022$1,053,000
+174.9%
41,771
+201.1%
0.02%
+316.7%
Q4 2021$383,000
-77.5%
13,872
-75.2%
0.01%
-82.4%
Q1 2021$1,700,000
-5.2%
55,845
-38.4%
0.03%
-33.3%
Q4 2020$1,794,000
+152.7%
90,701
+66.5%
0.05%
+64.5%
Q3 2020$710,000
-17.9%
54,467
-28.6%
0.03%
-27.9%
Q2 2020$865,000
-69.1%
76,264
-24.3%
0.04%
-46.2%
Q2 2019$2,798,000
-23.7%
100,707
-8.8%
0.08%
-47.4%
Q1 2019$3,667,000
+65.8%
110,461
+45.1%
0.15%
+245.5%
Q4 2018$2,212,000
-12.9%
76,109
+37.9%
0.04%
-31.2%
Q3 2018$2,539,000
+64.8%
55,185
+33.8%
0.06%
+18.5%
Q2 2018$1,541,000
+210.1%
41,246
+145.4%
0.05%
+237.5%
Q1 2018$497,000
+31.5%
16,807
-14.7%
0.02%
+33.3%
Q1 2017$378,000
-51.8%
19,700
-58.1%
0.01%
-40.0%
Q4 2016$784,000
+20.1%
47,033
+48.2%
0.02%
+33.3%
Q3 2016$653,000
+50.5%
31,742
+124.1%
0.02%
+66.7%
Q2 2016$434,000
-48.2%
14,167
-36.7%
0.01%
-57.1%
Q1 2016$838,000
-9.2%
22,391
+4.7%
0.02%
-19.2%
Q4 2015$923,000
+118.2%
21,386
+89.7%
0.03%
+85.7%
Q3 2015$423,000
+90.5%
11,274
+73.0%
0.01%
+75.0%
Q4 2014$222,000
-27.9%
6,518
-18.3%
0.01%
-27.3%
Q3 2014$308,000
-38.3%
7,976
-37.8%
0.01%
-42.1%
Q2 2014$499,000
+111.4%
12,833
+85.9%
0.02%
+90.0%
Q1 2014$236,000
-91.6%
6,905
-94.8%
0.01%
-92.6%
Q4 2013$2,800,000
+188.4%
133,442
+223.1%
0.14%
+240.0%
Q3 2013$971,000
-3.4%
41,300
+10.4%
0.04%
-46.7%
Q2 2013$1,005,00037,4000.08%
Other shareholders
MYRIAD GENETICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders